Extending the life span of dendritic cells improves the potency of cancer vaccines.
References
Nestle, F.O., Banchereau, J. & Hart, D. Nat. Med. 7, 761–765 (2001).
Park, D., Lapteva, N., Seethammagari, M., Slawin, K.M. & Spencer, D.M. Nat. Biotechnol. 24, 1581–1590 (2006).
Banchereau, J. & Steinman, R.M. Nature 392, 245–252 (1998).
Reis e Sousa, C. Nat. Rev. Immunol. 6, 476–483 (2006).
Schadendorf, D. et al. Ann. Oncol. 17, 563–570 (2006).
Small, E.J. et al. J. Clin. Oncol. 24, 3089–3094 (2006).
Srivastava, P.K. Curr. Opin. Immunol. 18, 201–205 (2006).
Josien, R. et al. J. Exp. Med. 191, 495–502 (2000).
Lowy, D.R. & Schiller, J.T. J. Clin. Invest. 116, 1167–1173 (2006).
Boon, T., Coulie, P.G., Van den Eynde, B.J. & van der Bruggen, P. Annu. Rev. Immunol. 24, 175–208 (2006).
Peggs, K.S., Quezada, S.A., Korman, A.J. & Allison, J.P. Curr. Opin. Immunol. 18, 206–213 (2006).
Pulendran, B. & Ahmed, R. Cell 124, 849–863 (2006).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nestle, F. A new lease on life for dendritic cell vaccines?. Nat Biotechnol 24, 1483–1484 (2006). https://doi.org/10.1038/nbt1206-1483
Issue Date:
DOI: https://doi.org/10.1038/nbt1206-1483
- Springer Nature America, Inc.